Navigation Links
Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011
Date:4/12/2011

igure 57: Bladder Cancer Therapeutics Market, France, Treatment Usage Patterns, 2001–2010 96

Figure 58: Bladder Cancer Therapeutics Market, France, Market Drivers and Restraints, 2010 98

Figure 59: Bladder Cancer Therapeutics Market, France, The Impact of Historical Events on the Market, 2010 100

Figure 60: Bladder Cancer Therapeutics Market, France, Sales Value ($m), 2011-2020 101

Figure 61: Bladder Cancer Therapeutics Market, France, Annual Cost of Therapy ($), 2011-2020 102

Figure 62: Bladder Cancer Therapeutics Market, France, Patient Volume (absolute), 2011-2020 103

Figure 63: Bladder Cancer Therapeutics Market, France, Treatment Usage Patterns, 2011-2020 104

Figure 64: Bladder Cancer Therapeutics Market, France, Future Market Drivers and Restraints, 2011–2020 106

Figure 65: Bladder Cancer Therapeutics Market, France, Drug Sales ($m), 2001-2020 107

Figure 66: Bladder Cancer Therapeutics Market, Italy, Sales Value ($m), 2001–2010 110

Figure 67: Bladder Cancer Therapeutics Market, Italy, Annual Cost of Therapy ($), 2001–2010 111

Figure 68: Bladder Cancer Therapeutics Market, Italy, Patient Volume (absolute), 2001–2010 112

Figure 69: Bladder Cancer Therapeutics Market, Italy, Treatment Usage Patterns, 2001–2010 113

Figure 70: Bladder Cancer Therapeutics Market, Italy, Market Drivers and Restraints, 2010 115

Figure 71: Bladder Cancer Therapeutics Market, Italy, The Impact of Historical Events on the Market, 2010 117

Figure 72: Bladder Cancer Therapeutics Market, Italy, Sales Value ($m), 2011-2020 118

Figure 73: Bladder Cancer Therapeutics Market, Italy, Annual Cost of Therapy ($), 2011-2020 119

Figure 74: Bladder Cancer Therapeutics Market, Italy, Patient Volume (absolute), 2011-2020 120

Figure 75: Bladder Cancer Therapeutics Market, Italy, Treatment Usage Patterns, 2011-2020 121

Figure 76: Bladder
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine technology :

1. Reportlinker Adds Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
2. Reportlinker Adds World In Vitro Diagnostics Market
3. Reportlinker Adds Global Market for Medical Devices, 2nd Edition
4. Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries)
5. Reportlinker Adds Asia Pacific Markets for Dental Bone Graft Substitutes and Other Biomaterials 2011
6. Reportlinker Adds European Markets for Interventional Cardiology Devices 2011 (15 Countries)
7. Reportlinker Adds Global: Pharmaceuticals Industry Guide
8. Reportlinker Adds Asian Vaccine Markets
9. Reportlinker Adds Microscopy Market in Latin America
10. Reportlinker Adds Leading Anti-Cancer Drugs: World Market Prospects 2011-2021
11. Reportlinker Adds Transdermal Drug Delivery - Technologies, Markets, and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Today the U.S. Food and ... for the prevention of serogroup B meningococcal disease ... Pfizer,s vaccine Trumenba®, which received FDA approval in October, ... devastating disease. "I have heard over ...
(Date:1/23/2015)... , Jan. 23, 2015  A new analysis of ... D 2015 enrollment data shows that 81 percent of ... access and extra discounts at certain pharmacies. The findings ... "Preferred pharmacy plans are now the foundation of Medicare ...
(Date:1/23/2015)... NEW YORK , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer ... the board of directors of Advaxis, Inc. ("Advaxis" or ... the board has breached its fiduciary duties to shareholders. ... published on an investing website reporting that Advaxis had ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2
... BioCryst Says Study Confirms and Extends Evidence Seen ... /PRNewswire-FirstCall/ --,BioCryst Pharmaceuticals, Inc. today announced that investigators,at ... results evaluating peramivir treatment in an animal model,of ... virus (an avian,influenza strain that had caused fatal ...
... data show efficacy across the range of migraine ... many migraine,sufferers experience traditional symptoms such as nausea ... also involve,symptoms like neck pain or sinus pain ... data show that,significantly more patients using the investigational ...
Cached Medicine Technology:St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 2St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 3St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 4St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 5St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 6Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both,Traditional and Non-traditional Migraine Symptoms 2Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both,Traditional and Non-traditional Migraine Symptoms 3Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both,Traditional and Non-traditional Migraine Symptoms 4Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both,Traditional and Non-traditional Migraine Symptoms 5
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently ... thrilled to have it lead the wedding dress industry into ... prom dresses for the global market. , “The CEO of ... he focuses on continuing the goal of operational excellence and ...
(Date:1/22/2015)... Minn. (PRWEB) January 22, 2015 Blue Cross ... those Minnesotans who exemplify what it means to “Live Fearless.” ... chance for people to share their stories about how they ... or simply inspired others by living in the moment. By ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Juvent Sports ... at the 2015 PGA Merchandise Show to bestow a ... incredible female amateur golfer, Arlene McKitrick. The award commemorated ... amateur golf tournament win. She won her first amateur ...
(Date:1/22/2015)... released a new blog post explaining the main features of ... Auto insurance quotes help many drivers find the best coverage ... an agent or visit an agency for price information. These ... http://autocarinsurancebest.com/ . , Every business who relies heavily on transportation ...
(Date:1/22/2015)... January 22, 2015 Joan Lunden, award-winning ... speaker at the upcoming 32nd Annual Miami Breast ... Physicians’ Education Resource®, LLC (PER®) , shares that “a ... gone undetected if she had not followed up her ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... $28 million increase in,abstinence-only program funding, ... a,statement by James Wagoner on the $28 ... we learned that the Democratic-controlled Labor HHS,Appropriations ... million,increase requested by President Bush for failed,abstinence-only-until-marriage ...
... Z Trim Holdings, Inc.,(Amex: ZTM ), reported today ... 8-K,with the Securities Exchange Commission ("SEC") disclosing that it ... determination by Z,Trim that those financial statements should no ... financial statements for the,quarters ended March 31, 2007 and ...
... Nov. 1 Masimo, the inventor,of Pulse CO-Oximetry ... the completion of CHN,s system-wide implementation of,Masimo SET ... superior,Masimo SET performance in other areas of its ... oximetry technology to virtually every site --,making Masimo ...
... NEW YORK, Nov. 1 A recent survey ... shows most do want wellness,programs in the workplace. ... interested in,employer- sponsored weight control programs. The survey ... experts on obesity, nutrition, diabetes,and healthcare policy. ...
... FAJARDO, Puerto Rico and EAST WINDSOR, N.J., Nov. ... Chilcott, Ltd., [Nasdaq: WCRX]) and NexMed, Inc. (Nasdaq: ... have entered into a licensing,agreement granting Warner Chilcott ... cream for the treatment of erectile,dysfunction (ED). NexMed ...
... 2007, as,the House Committee on Foreign Affairs convened ... States Conference of Catholic Bishops (USCCB) ran,ads in ... to support,"that sensible policy." The Mexico City Policy, ... fund foreign non-governmental organizations,that promote abortion as family ...
Cached Medicine News:Health News:Democrats Cave on Sex Education - Again 2Health News:Z Trim Holdings Reports Restatement of Previously Issued Financial Statements; Amends Bylaws 2Health News:Z Trim Holdings Reports Restatement of Previously Issued Financial Statements; Amends Bylaws 3Health News:Z Trim Holdings Reports Restatement of Previously Issued Financial Statements; Amends Bylaws 4Health News:Z Trim Holdings Reports Restatement of Previously Issued Financial Statements; Amends Bylaws 5Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 2Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 3Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 4Health News:Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction 2Health News:Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction 3Health News:Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction 4Health News:U.S. Catholic Bishops' Pro-Life Secretariat to Congress: Support the Mexico City Policy 2
... Growth Stimulator is a portable, battery-powered bone growth ... fusion. The device is worn for 30 minutes ... to the fusion site. The device uses a ... very low energy signal that is very potent ...
... Frontier device is a multi-site, ... one atrial and two ventricular ... atrial fibrillation (AF) who have ... and who have NYHA Class ...
Intrinsic Dual Chamber ICD With MVP Mode (Managed Ventricular Pacing). MVP promotes intrinsic conduction and is clinically proven to reduce unnecessary right ventricular (RV) pacing to approximately...
... to 8 Fr. access sites following diagnostic or ... System is indicated for the percutaneous delivery of ... site of patients who have undergone diagnostic or ... The Closer S 6F SMC System reduces the ...
Medicine Products: